(Q44774130)

6 December 2017

title

Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis (English)

1 reference

6 December 2017

1 reference

Yoshiko Nomura

1

1 reference

6 December 2017

Masaya Segawa

series ordinal

2

1 reference

6 December 2017

publication date

1 December 2003

1 reference

6 December 2017

published in

Brain and Development

1 reference

6 December 2017

volume

25 Suppl 1

1 reference

6 December 2017

page(s)

S37-42

1 reference

Gilles de la tourette syndrome in oriental children

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Tourette syndrome, associated conditions and the complexities of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Gilles de la Tourette Syndrome Is Not Linked to D2-Dopamine Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Dopaminergic dysfunction in tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

The treatment of tics

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Brain monoamines and amino acids in Gilles de la Tourette's syndrome: a preliminary study of subcortical regions

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

123Ibeta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

High presynaptic dopaminergic activity in children with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Dopamine transporter binding in Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Dopamine D2 receptor imaging in Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Increased ventral striatal monoaminergic innervation in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

6-hydroxy-dopamine induced degeneration of central monoamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Effects of Dopamine Agonists and Antagonists in Tourette's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

Response to levodopa challenge in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2990007-6

7 January 2021

10.1016/S0387-7604(03)90007-6

Identifiers

DOI

1 reference

6 December 2017

1 reference